Vitamin C decreases VEGF expression levels via hypoxia‑inducible factor‑1α dependent and independent pathways in lens epithelial cells

Zhao,Lin; Wang,Jianming; Zhang,Yi; Wang,Lijun; Yu,Miao; Wang,Feng

doi:10.3892/mmr.2020.11103

Vitamin C decreases VEGF expression levels via hypoxia‑inducible factor‑1α dependent and independent pathways in lens epithelial cells

Authors:
- Lin Zhao
- Jianming Wang
- Yi Zhang
- Lijun Wang
- Miao Yu
- Feng Wang
View Affiliations

Affiliations: Department of Ophthalmology, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi 710004, P.R. China
Published online on: April 30, 2020 https://doi.org/10.3892/mmr.2020.11103
Pages: 436-444
Copyright: © Zhao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Posterior capsular opacification (PCO) is the main complication following cataract surgery. The proliferation of the residual lens epithelial cells (LECs) serves an important role in PCO formation. The authors' previous study revealed that vitamin C inhibited the proliferation of human LECs by increasing the rapid degradation of hypoxia‑inducible factor‑1 (HIF‑1α), and hence inhibited the expression of vascular endothelial growth factor (VEGF). The present study aimed to further investigate the mechanisms underlying the effects of vitamin C on the expression levels of VEGF. The present study demonstrated that the HIF‑1 inhibitor BAY 87‑2243 significantly inhibited the cell proliferation and the expression levels of VEGF in LECs through the use of colony formation, western blotting and ELISA assays. Moreover, it was revealed that vitamin C could further inhibit the cell proliferation and the expression levels of VEGF in LECs following the cotreatment with the HIF‑1 inhibitor. The proline hydroxylation of HIF‑1α by prolyl hydroxylases (PHDs) was previously discovered to be responsible for the rapid degradation of HIF‑1α. Thus, the present study subsequently used three PHD inhibitors to investigate their effects on the expression levels of VEGF; it was found that the PHD2 specific inhibitor increased the expression levels of VEGF to the greatest extent. Moreover, the genetic knockdown of PHD2 by lentiviral transfection also significantly increased the expression levels of VEGF, whereas the PHD2 specific inhibitor did not alter the expression levels of VEGF in the PHD2 knockdown LECs. AKT kinase activity is an important mediator known to upregulate VEGF expression. Using an immunoprecipitation assay to isolate endogenous AKT, it was demonstrated that AKT was prolyl hydroxylated by PHD2, which inhibited its activity. It was also revealed that vitamin C enhanced the proline‑hydroxylation and inhibited the activity of AKT. Furthermore, an AKT inhibitor increased the effects of vitamin C on the expression levels of VEGF. However, the AKT inhibitor did not affect the expression levels of glucose transporter 1, which is a HIF‑1α target gene. In conclusion, the findings of the present study suggested that vitamin C may inhibit the expression levels of VEGF via HIF‑1α‑dependent and AKT‑dependent pathways in LECs.

View Figures

View References

1	Raj SM, Vasavada AR, Johar SR and Vasavada VA and Vasavada VA: Post-operative capsular opacification: A review. Int J Biomed Sci. 3:237–250. 2007.PubMed/NCBI
2	Moulick PS, Rodrigues F and Shyamsundar K: Evaluation of posterior capsular opacification following phacoemulsification, extracapsular and small incision cataract surgery. Med J Armed Forces India. 65:225–228. 2009. View Article : Google Scholar : PubMed/NCBI
3	Duman R, Karel F, Özyol P and Ates C: Effect of four different intraocular lenses on posterior capsule opacification. Int J Ophthalmol. 8:118–121. 2015.PubMed/NCBI
4	Zukin LM, Pedler MG, Groman-Lupa S, Pantcheva M, Ammar DA and Petrash JM: Aldose reductase inhibition prevents development of posterior capsular opacification in an in vivo model of cataract surgery. Invest Ophthalmol Vis Sci. 59:3591–3598. 2018. View Article : Google Scholar : PubMed/NCBI
5	Zhang C, Liu J, Jin N, Zhang G, Xi Y and Liu H: SiRNA targeting mTOR effectively prevents the proliferation and migration of human lens epithelial cells. PLoS One. 11:e01673492016. View Article : Google Scholar : PubMed/NCBI
6	Andjelić S, Drašlar K, Lumi X, Yan X, Graw J, Facskó A, Hawlina M and Petrovski G: Morphological and proliferative studies on ex vivo cultured human anterior lens epithelial cells-relevance to capsular opacification. Acta Ophthalmol. 93:e499–e506. 2015. View Article : Google Scholar : PubMed/NCBI
7	Abdelkader H, Alany RG and Pierscionek B: Age-related cataract and drug therapy: Opportunities and challenges for topical antioxidant delivery to the lens. J Pharm Pharmacol. 67:537–550. 2015. View Article : Google Scholar : PubMed/NCBI
8	Chang JR, Koo E, Agrón E, Hallak J, Clemons T, Azar D, Sperduto RD, Ferris FL III and Chew EY; Age-Related Eye Disease Study Group, : Risk factors associated with incident cataracts and cataract surgery in the age-related eye disease study (AREDS): AREDS report number 32. Ophthalmology. 118:2113–2119. 2011. View Article : Google Scholar : PubMed/NCBI
9	Thiagarajan R and Manikandan R: Antioxidants and cataract. Free Radic Res. 47:337–345. 2013. View Article : Google Scholar : PubMed/NCBI
10	Zhao L, Quan Y, Wang J, Wang F, Zheng Y and Zhou A: Vitamin C inhibit the proliferation, migration and epithelial-mesenchymal- transition of lens epithelial cells by destabilizing HIF-1α. Int J Clin Exp Med. 8:15155–15163. 2015.PubMed/NCBI
11	Kaur A, Gupta V, Christopher AF, Malik MA and Bansal P: Nutraceuticals in prevention of cataract-An evidence based approach. Saudi J Ophthalmol. 31:30–37. 2017. View Article : Google Scholar : PubMed/NCBI
12	Valero MP, Fletcher AE, De Stavola BL, Vioque J and Alepuz VC: Vitamin C is associated with reduced risk of cataract in a mediterranean population. J Nutr. 132:1299–1306. 2002. View Article : Google Scholar : PubMed/NCBI
13	Yum S, Jeong S, Kim D, Lee S, Kim W, Yoo JW, Kim JA, Kwon OS, Kim DD, Min DS and Jung Y: Minoxidil induction of VEGF is mediated by inhibition of HIF-prolyl hydroxylase. Int J Mol Sci. 19(pii): E532017. View Article : Google Scholar : PubMed/NCBI
14	Zhang Y, Xu Y, Ma J, Pang X and Dong M: Adrenomedullin promotes angiogenesis in epithelial ovarian cancer through upregulating hypoxia-inducible factor-1α and vascular endothelial growth factor. Sci Rep. 7:405242017. View Article : Google Scholar : PubMed/NCBI
15	Takei A, Ekström M, Mammadzada P, Aronsson M, Yu M, Kvanta A and André H: Gene transfer of prolyl hydroxylase domain 2 inhibits hypoxia-inducible angiogenesis in a model of choroidal neovascularization. Sci Rep. 7:425462017. View Article : Google Scholar : PubMed/NCBI
16	Xiong GF, Stewart RL, Chen J, Gao T, Scott TL, Samayoa LM, O'Connor K, Lane AN and Xu R: Collagen prolyl 4-hydroxylase 1 is essential for HIF-1α stabilization and TNBC chemoresistance. Nat Commun. 9:44562018. View Article : Google Scholar : PubMed/NCBI
17	Kuiper C and Vissers MC: Ascorbate as a co-factor for fe- and 2-oxoglutarate dependent dioxygenases: Physiological activity in tumor growth and progression. Front Oncol. 4:3592014. View Article : Google Scholar : PubMed/NCBI
18	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
19	Zhou L, Wang Y, Zhou M, Zhang Y, Wang P, Li X, Yang J, Wang H and Ding Z: HOXA9 inhibits HIF-1α-mediated glycolysis through interacting with CRIP2 to repress cutaneous squamous cell carcinoma development. Nat Commun. 9:14802018. View Article : Google Scholar : PubMed/NCBI
20	Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, et al: Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature. 394:485–490. 1998. View Article : Google Scholar : PubMed/NCBI
21	Finley LW, Carracedo A, Lee J, Souza A, Egia A, Zhang J, Teruya-Feldstein J, Moreira PI, Cardoso SM, Clish CB, et al: SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization. Cancer Cell. 19:416–428. 2011. View Article : Google Scholar : PubMed/NCBI
22	Groulx I and Lee S: Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclear-cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein. Mol Cell Biol. 22:5319–5336. 2002. View Article : Google Scholar : PubMed/NCBI
23	Shiozaki A, Shen-Tu G, Bai X, Iitaka D, De Falco V, Santoro M, Keshavjee S and Liu M: XB130 mediates cancer cell proliferation and survival through multiple signaling events downstream of Akt. PLoS One. 7:e436462012. View Article : Google Scholar : PubMed/NCBI
24	Karar J and Maity A: PI3K/AKT/mTOR pathway in angiogenesis. Front Mol Neurosci. 4:512011. View Article : Google Scholar : PubMed/NCBI
25	Guo J, Chakraborty AA, Liu P, Gan W, Zheng X, Inuzuka H, Wang B, Zhang J, Zhang L, Yuan M, et al: pVHL suppresses kinase activity of Akt in a proline-hydroxylation-dependent manner. Science. 353:929–932. 2016. View Article : Google Scholar : PubMed/NCBI
26	Woo YM, Shin Y, Lee EJ, Lee S, Jeong SH, Kong HK, Park EY, Kim HK, Han J, Chang M and Park JH: Inhibition of aerobic glycolysis represses Akt/mTOR/HIF-1α axis and restores tamoxifen sensitivity in antiestrogen-resistant breast cancer cells. PLoS One. 10:e01322852015. View Article : Google Scholar : PubMed/NCBI
27	Pore N, Jiang Z, Shu HK, Bernhard E, Kao GD and Maity A: Akt1 activation can augment hypoxia-inducible factor-1alpha expression by increasing protein translation through a mammalian target of rapamycin-independent pathway. Mol Cancer Res. 4:471–479. 2006. View Article : Google Scholar : PubMed/NCBI
28	Li JH, Wang NL and Wang JJ: Expression of matrix metalloproteinases of human lens epithelial cells in the cultured lens capsule bag. Eye (Lond). 22:439–444. 2008. View Article : Google Scholar : PubMed/NCBI
29	Chandler HL, Barden CA, Lu P, Kusewitt DF and Colitz CM: Prevention of posterior capsular opacification through cyclooxygenase-2 inhibition. Mol Vis. 13:677–691. 2007.PubMed/NCBI
30	Shi GH and Zhou L: Emodin suppresses angiogenesis and metastasis in anaplastic thyroid cancer by affecting TRAF6-mediated pathways in vivo and in vitro. Mol Med Rep. 18:5191–5197. 2018.PubMed/NCBI
31	Palazon A, Tyrakis PA, Macias D, Veliça P, Rundqvist H, Fitzpatrick S, Vojnovic N, Phan AT, Loman N, Hedenfalk I, et al: An HIF-1α/VEGF-A axis in cytotoxic T cells regulates tumor progression. Cancer Cell. 32:669–683 e665.e5. 2017. View Article : Google Scholar : PubMed/NCBI
32	Zhang Z, Yao L, Yang J, Wang Z and Du G: PI3K/Akt and HIF-1 signaling pathway in hypoxia-ischemia (Review). Mol Med Rep. 18:3547–3554. 2018.PubMed/NCBI
33	Choi SB, Park JB, Song TJ and Choi SY: Molecular mechanism of HIF-1-independent VEGF expression in a hepatocellular carcinoma cell line. Int J Mol Med. 28:449–454. 2011.PubMed/NCBI
34	Arsham AM, Plas DR, Thompson CB and Simon MC: Akt and hypoxia-inducible factor-1 independently enhance tumor growth and angiogenesis. Cancer Res. 64:3500–3507. 2004. View Article : Google Scholar : PubMed/NCBI
35	Satheesh NJ, Samuel SM and Busselberg D: Combination therapy with vitamin c could eradicate cancer stem cells. Biomolecules. 10(pii): E792020. View Article : Google Scholar : PubMed/NCBI
36	Fischer AP and Miles SL: Ascorbic acid, but not dehydroascorbic acid increases intracellular vitamin C content to decrease hypoxia inducible factor-1 alpha activity and reduce malignant potential in human melanoma. Biomed Pharmacother. 86:502–513. 2017. View Article : Google Scholar : PubMed/NCBI
37	Jaakkola P, Mole DR, Tian YM, Wilson M, Gielbert J, Gaskell SJ, von Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, et al: Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 292:468–472. 2001. View Article : Google Scholar : PubMed/NCBI
38	Marxsen JH, Stengel P, Doege K, Heikkinen P, Jokilehto T, Wagner T, Jelkmann W, Jaakkola P and Metzen E: Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases. Biochem J. 381:761–767. 2004. View Article : Google Scholar : PubMed/NCBI
39	Kawasaki Y, Fujiki M, Uchida S, Morishige M, Momii Y and Ishii K: A single oral dose of geranylgeranylacetone upregulates vascular endothelial growth factor and protects against kainic acid-induced neuronal cell death: Involvement of the phosphatidylinositol-3 kinase/akt pathway. Pathobiology. 84:184–191. 2017. View Article : Google Scholar : PubMed/NCBI
40	Lindsey RC, Cheng S and Mohan S: Vitamin C effects on 5-hydroxymethylcytosine and gene expression in osteoblasts and chondrocytes: Potential involvement of PHD2. PLoS One. 14:e02206532019. View Article : Google Scholar : PubMed/NCBI
41	Xing W, Pourteymoor S and Mohan S: Ascorbic acid regulates osterix expression in osteoblasts by activation of prolyl hydroxylase and ubiquitination-mediated proteosomal degradation pathway. Physiol Genomics. 43:749–757. 2011. View Article : Google Scholar : PubMed/NCBI
42	Lee HY, Lee T, Lee N, Yang EG, Lee C, Lee J, Moon EY, Ha J and Park H: Src activates HIF-1α not through direct phosphorylation of HIF-1α specific prolyl-4 hydroxylase 2 but through activation of the NADPH oxidase/Rac pathway. Carcinogenesis. 32:703–712. 2011. View Article : Google Scholar : PubMed/NCBI